LZK polyclonal, anti-human, mouse, rat
€470.00
In stock
SKU
AC-AP70793
Background:
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
Other Names:
MAP3K13; LZK; Mitogen-activated protein kinase kinase kinase 13; Leucine zipper-bearing kinase; Mixed lineage kinase; MLK
Antigen Type: synthetic peptide
Antigen Type: MAP3K13 (HGNC:6852)
Gene ID: 9175
Primary Accession: O43283
Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
Other Names:
MAP3K13; LZK; Mitogen-activated protein kinase kinase kinase 13; Leucine zipper-bearing kinase; Mixed lineage kinase; MLK
Antigen Type: synthetic peptide
Antigen Type: MAP3K13 (HGNC:6852)
Gene ID: 9175
Primary Accession: O43283
| Is Featured? | No |
|---|
Write Your Own Review